Management of Fever During Blood Transfusion

Immediate Action

• The transfusion must be stopped immediately when fever develops and should not be resumed until a thorough investigation excludes serious transfusion reactions. American Society of Anesthesiologists recommendation. 1
• Stopping the transfusion is the critical first step because fever may signal life‑threatening complications such as bacterial contamination, hemolytic reaction, or TRALI. American Society of Anesthesiologists guidance. 2

Assessment of Life‑Threatening Reactions

Bacterial Contamination (Sepsis)

• Platelet transfusions, stored at 20‑24 °C, are the product most frequently associated with bacterial contamination. American Society of Anesthesiologists data. 2
• Clinical picture includes hyperthermia and hypotension. American Society of Anesthesiologists observation. 3
• Fever occurring within 6 hours of a platelet transfusion should raise strong suspicion for bacterial contamination. American Society of Anesthesiologists guideline. 2
• Management requires immediate cessation of the transfusion, administration of antibiotics, and supportive measures. American Society of Anesthesiologists protocol. 3

Transfusion‑Related Acute Lung Injury (TRALI)

• TRALI ranks among the top three causes of transfusion‑related mortality. American Society of Anesthesiologists statement. 2
• Symptoms typically appear 1–2 hours after transfusion, reaching maximum severity around 6 hours. American Society of Anesthesiologists timing data. 2
• Presentation includes fever, hypoxia, dyspnea, acute respiratory distress, and a rise in peak airway pressure. American Society of Anesthesiologists clinical description. 3
• Treatment consists of stopping the transfusion and providing critical‑care supportive measures. American Society of Anesthesiologists recommendation. 2

Hemolytic Transfusion Reaction

• Key signs are fever, hypotension, tachycardia, hemoglobinuria, and microvascular bleeding. American Society of Anesthesiologists identification. 1
• The fatal hemolysis rate is approximately 8 per 10 million red‑blood‑cell units. American Society of Internal Medicine estimate. 4
• Immediate cessation of the transfusion and prompt diagnostic testing are required. American Society of Anesthesiologists directive. 1

Specific Reaction Types

Febrile Non‑Hemolytic Transfusion Reaction (FNHTR)

• FNHTR is the most common reaction in awake patients, manifesting as fever, chills, or urticaria. American Society of Anesthesiologists observation. 1
• Red‑blood‑cell units are the product most frequently associated with FNHTR. Anaesthesia guideline. 5
• For isolated FNHTR, a personalized approach recommends intravenous paracetamol as the primary therapy. Anaesthesia recommendation. 5
• Steroids and antihistamines should not be used indiscriminately, as they may further suppress immunity in immunocompromised patients. Anaesthesia caution. 5

Allergic Reactions

• Allergic reactions are more commonly triggered by plasma and platelet products. Anaesthesia data. 5
• When urticaria is present without severe features, treatment should be limited to an antihistamine. Anaesthesia guidance. 5
• Suspected severe allergic reactions or anaphylaxis require adherence to local anaphylaxis protocols. Anaesthesia protocol. 5

Diagnostic Evaluation Before Further Transfusion

• Prior to any additional transfusion, order direct and indirect antiglobulin tests to exclude hemolysis, assess urine output and color for hemoglobinuria, and monitor peak airway pressure when applicable. American Society of Anesthesiologists recommendation. 1
• Urine output/color assessment and peak airway pressure monitoring are specifically highlighted for detecting hemolysis and TRALI, respectively. American Society of Anesthesiologists specifics. 6

Post‑Reaction Management

• The same unit of blood must never be resumed after a transfusion reaction. American Society of Anesthesiologists rule. 1

Monitoring Guidelines

• Continuous monitoring schedule: baseline observations within 60 minutes before transfusion start, 15 minutes after the start of each unit, and within 60 minutes after transfusion completion. Anaesthesia monitoring protocol. 5
• Respiratory rate should be vigilantly observed, as dyspnea and tachypnea are early indicators of serious transfusion reactions. Anaesthesia emphasis. 5

Monitoring and Management Recommendations for Acute Hemolytic Transfusion Reactions

Bedside Monitoring

• Continuous monitoring of vital signs—including pulse, blood pressure, temperature, and respiratory rate—is essential during the first minutes of an acute hemolytic transfusion reaction to detect rapid hemodynamic deterioration. 7

Ongoing Monitoring (Hours–Days)

• Vital signs should be recorded at baseline, then 15 minutes after any therapeutic intervention, and subsequently at hourly intervals to track stability and response to treatment. 7

Investigation of Cause

• A systematic review of all patient identification and blood‑product matching steps is required to uncover potential wrong‑blood‑administration errors that may have precipitated the reaction. 7

Medication Pitfalls

• Steroids and antihistamines should not be administered routinely for acute hemolytic transfusion reactions, as they are not indicated and may suppress the immune response. 7

Fever During the First Hour of Blood Transfusion – Evidence‑Based Management

Immediate Management Steps

• Switch the intravenous line to normal saline at a keep‑vein‑open (KVO) rate while the transfusion is halted. American Society of Hematology recommendation. 8
• Perform a rapid physical assessment of vital signs (blood pressure, pulse, respiratory rate, oxygen saturation, temperature) before any further action. American Society of Hematology guidance. 8

Life‑Threatening Reactions

Bacterial Contamination (Septic Transfusion Reaction)

• Suspect bacterial contamination when fever develops within 6 hours of a platelet transfusion, because platelets are stored at 20‑24 °C, which permits bacterial growth. American Society of Anesthesiologists evidence. 9
• Typical presentation includes hyperthermia together with hypotension. American Society of Anesthesiologists observation. 9
• Management: immediately stop the transfusion, start broad‑spectrum antibiotics, and provide fluid resuscitation as supportive care. American Society of Anesthesiologists protocol. 9

Transfusion‑Related Acute Lung Injury (TRALI)

• TRALI is a leading cause of transfusion‑related mortality. American Society of Anesthesiologists statement. 9
• Symptoms usually appear 1‑2 hours after the transfusion and reach maximal severity by 6 hours. American Society of Anesthesiologists data. 10
• Key clinical features: fever, hypoxemia, dyspnea, acute respiratory distress, and an increase in peak airway pressure. American Society of Anesthesiologists description. 9
• Management: stop the transfusion and deliver critical‑care support, including supplemental oxygen and mechanical ventilation when indicated. American Society of Anesthesiologists recommendation. 9

Acute Hemolytic Transfusion Reaction

• Clinical signs include fever, hypotension, tachycardia, dark/red urine (hemoglobinuria), and microvascular bleeding. American Society of Anesthesiologists evidence. 10
• Management steps: halt the transfusion, order direct and indirect antiglobulin (Coombs) tests, and monitor urine output and color for hemoglobinuria. American Society of Anesthesiologists guidance. 10
• In intubated patients, monitor peak airway pressure for early detection of pulmonary involvement. American Society of Anesthesiologists recommendation. 10

Allergic Reactions

Mild Allergic Reaction (Urticaria without Severe Features)

• Treat with a single dose of an antihistamine (e.g., diphenhydramine) only. American Society of Anesthesiologists advice. 9

Severe Allergic Reaction / Anaphylaxis

• Administer intramuscular epinephrine 0.3 mg into the anterolateral thigh immediately. American Society of Hematology protocol. 8
• Follow local anaphylaxis algorithms and provide supportive care (IV fluids, oxygen, consider albuterol nebulization). American Society of Hematology guidance. 8

Diagnostic Workup Before Further Transfusion

• Obtain direct and indirect antiglobulin (DAT/IAT) tests to exclude hemolysis. American Society of Anesthesiologists recommendation. 10
• Assess urine output and color for hemoglobinuria as part of the hemolysis evaluation. American Society of Anesthesiologists instruction. 10
• Monitor peak airway pressure in ventilated patients to help detect TRALI early. American Society of Anesthesiologists suggestion. 10
• If bacterial contamination is suspected, draw blood cultures from both the patient and any remaining blood product. American Society of Anesthesiologists directive. 10

Monitoring Considerations Under General Anesthesia

• General anesthesia can mask typical transfusion reaction signs (fever, chills, urticaria); therefore, continuous vigilance of vital signs, urine output/color, and peak airway pressure is essential. American Society of Anesthesiologists recommendation. 10

Post‑Reaction Observation

• After treating a febrile non‑hemolytic transfusion reaction, monitor the patient for at least 15 minutes before concluding the episode. American Society of Hematology guideline. 8